UBS Group
OPK icon

UBS Group’s Opko Health OPK Stock Holding History

UBS Group’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-500,000
Closed -$5.29M – 7958
2016
Q3 		$5.29M Hold
500,000
– – ﹤0.01% 1969
2016
Q2 		$4.67M Buy
500,000
+471,400
+1,648% +$4.79M ﹤0.01% 2000
2016
Q1 		$297K Buy
28,600
+27,900
+3,986% +$255K ﹤0.01% 4187
2015
Q4 		$7K Hold
700
– – ﹤0.01% 7522
2015
Q3 		$6K Sell
700
-5,000
-88% -$66.2K ﹤0.01% 7609
2015
Q2 		$92K Hold
5,700
– – ﹤0.01% 5467
2015
Q1 		$81K Sell
5,700
-55,300
-91% -$720K ﹤0.01% 5601
2014
Q4 		$609K Buy
+61,000
New +$522K ﹤0.01% 4017

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group's OPK Position: Q1 2026 in Review

UBS Group increased its Opko Health (OPK) stake by 13% in Q1 2026, buying an estimated $885K and bringing the position to 6,071,432 shares worth $6.92M. The position accounts for ﹤0.01% of the portfolio, ranked #3730.

UBS Group first reported a position in OPK in Q4 2014 and has held it in 46 quarters since. The position peaked at $19.9M in Q3 2017. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • UBS Group held 6,071,432 shares of Opko Health worth $6.92M as of Q1 2026.
  • UBS Group bought 718,648 Opko Health shares in Q1 2026, an estimated $885K.
  • Opko Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3730 holding.
  • UBS Group first reported a position in Opko Health in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Opko Health position peaked at $19.9M in Q3 2017.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.